Cargando…

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

OBJECTIVE: WHO recommends ritonavir-boosted protease inhibitor with two nucleoside reverse transcriptase inhibitors in HIV-infected patients failing non-nucleoside reverse transcriptase inhibitor-based first-line treatment. Here, we aimed to provide more evidence for the choice of nucleoside reverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciaffi, Laura, Koulla-Shiro, Sinata, Sawadogo, Adrien, le Moing, Vincent, Eymard-Duvernay, Sabrina, Izard, Susanne, Kouanfack, Charles, Ngom Gueye, Ndeye Fatou, Fobang, Avelin Aghokeng, Reynes, Jacques, Calmy, Alexandra, Delaporte, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502989/ https://www.ncbi.nlm.nih.gov/pubmed/26244387 http://dx.doi.org/10.1097/QAD.0000000000000709

Ejemplares similares

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
por: Kabore, Nongodo Firmin, et al.
Publicado: (2021)

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
por: Mbougua, Jules B Tchatchueng, et al.
Publicado: (2010)

Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal
por: Cournil, Amandine, et al.
Publicado: (2012)

Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors
por: Diouf, Assane, et al.
Publicado: (2012)

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa
por: Boyer, S., et al.
Publicado: (2019)

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study
por: Kabore, Firmin Nongodo, et al.
Publicado: (2017)

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
por: Laurent, Christian, et al.
Publicado: (2006)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment
por: Bigna, Jean Joel R., et al.
Publicado: (2015)

A randomized blinded controlled trial of mobile phone reminders on the follow-up medical care of HIV-exposed and HIV-infected children in Cameroon: study protocol (MORE CARE)
por: Bigna, Jean Joel R, et al.
Publicado: (2013)

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal
por: Canestri, Anna, et al.
Publicado: (2007)

Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
por: Etard, Jean-François, et al.
Publicado: (2009)

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance
por: Billong, Serge C., et al.
Publicado: (2013)

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
por: Boullé, Charlotte, et al.
Publicado: (2016)

Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study
por: Namme Luma, Henry, et al.
Publicado: (2012)

Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting
por: Kaboré, Nongodo Firmin, et al.
Publicado: (2019)

Bacterial Etiology and Antibiotic Resistance Profile of Community-Acquired Urinary Tract Infections in a Cameroonian City
por: Nzalie, Rolf Nyah-tuku, et al.
Publicado: (2016)

Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort
por: De Beaudrap, Pierre, et al.
Publicado: (2010)

Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003–2005
por: Tsague, Landry, et al.
Publicado: (2008)

HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2019)

Facteurs associés à la dissociation immunovirologique chez les patients infectés par le VIH-1 sous traitement antirétroviral hautement actif au Centre de Traitement Ambulatoire (CTA) de Dakar
por: Kà, Daye, et al.
Publicado: (2017)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon
por: Liégeois, Florian, et al.
Publicado: (2012)

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2019)

Prise en charge de la hernie diaphragmatique congénitale en Afrique sub-Saharienne: l’expérience du Centre Hospitalier National d’Enfants Albert Royer au Sénégal
por: Mbaye, Papa Alassane, et al.
Publicado: (2022)

Genetic diversity of simian lentivirus in wild De Brazza’s monkeys (Cercopithecus neglectus) in Equatorial Africa
por: Aghokeng, Avelin F., et al.
Publicado: (2010)

Eviscération transanale de l´intestin grêle par empalement chez l´enfant: à propos d´un cas
por: Wellé, Ibrahima Bocar, et al.
Publicado: (2020)

Choledochal Cyst in Children in Dakar: Diagnostic and Therapeutic Aspects
por: Ndoye, Ndèye Aby, et al.
Publicado: (2021)

Assessment of potentially preventable hospitalizations in the regional hospital of Saint-Louis, Senegal
por: Ndiaye, Abdoul Aziz, et al.
Publicado: (2017)

Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
por: Dieye, Tandakha N., et al.
Publicado: (2013)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
por: Dieye, Tandakha N., et al.
Publicado: (2013)

ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015)
por: Ngom, Ndeye Fatou, et al.
Publicado: (2018)

Differential insecticide resistance in Anopheles arabiensis populations in the seaside area of Mbour and its suburbs in Senegal
por: Sabaly, Penda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bjcf4fefg64rha91vdf2mrtqat